Lv1
26 积分 2022-02-08 加入
Paneth-like transition drives resistance to dual targeting of KRAS and EGFR in colorectal cancer
3天前
已完结
Therapy-induced senescence is a transient drug resistance mechanism in breast cancer
1个月前
已完结
ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma
1个月前
已完结
NNMT promotes acquired EGFR-TKI resistance by forming EGR1 and lactate-mediated double positive feedback loops in non-small cell lung cancer
2个月前
已完结
Targeting SERPINB3–MAPK axis-mediated cuproptosis resistance enhances the response to antitumor immunotherapy
2个月前
已完结
Prognostic and predictive role of circulating tumor DNA (ctDNA) in stage III colon cancer treated with celecoxib: Findings from CALGB (Alliance)/SWOG 80702
5个月前
已完结
Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer
5个月前
已完结
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial
5个月前
已完结
KRAS and MYC synergistic inhibition: a powerful strategy targeting KRAS-mutant cancers
5个月前
已完结
Heparin prevents caspase-11-dependent septic lethality independent of anticoagulant properties
6个月前
已完结
皖公网安备34019202002308
